About
Kangronsten (康诺思腾), founded in 2019 in Shenzhen, China, develops laparoscopic surgical robots.
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Founders / core team
Investors
Funding history
- 2025-11Series D+$200M
Investors · Qiming Venture Partners、高榕创投、香港投资管理有限公司
- 2025-01Series C$71M
Investors · Alpha JWC Ventures、创科创投基金、Alpha Startups、Qiming Venture Partners、殷拓集团
Source · SVTR Weekly #088
Similar companies· Same sector “Robotics”
磅策医疗
RoboticsPangce Medical (磅策医疗), founded in Shanghai, China in 2019, is a developer of medical surgical robots focused on core technologies including orthopedic and surgical robots and navigation positioning. The current funding round will be used for core technology iteration, new product pipeline R&D and clinical registration, commercialization channel expansion, and global market development.
瑞龙外科
RoboticsRuilong Surgical, founded in 2019 in Shanghai, China, develops minimally invasive surgical robots. Its core product, Haishan I®, features a split/modular design and has initiated regulatory submissions in Europe and South America. The company's Yangzhou global manufacturing base began operations in 2025, and it has established a strategic partnership with Johnson & Johnson MedTech.
智愈医疗
RoboticsZhiyu Medical, founded in 2021 in Beijing, China, is a developer of surgical robots.
CMR Surgical
RoboticsCMR Surgical, founded in 2014 in Cambridge, UK, sells robotic surgical systems to hospitals to assist surgeons in performing procedures for cancer and bowel disease treatment.
Neocis
RoboticsNeocis, founded in 2013 in Miami, USA, develops robotic systems to assist dental surgeries.
Capstan Medical
RoboticsCapstan Medical, founded in 2019 in Santa Cruz, California, develops robotic systems that enable physicians to implant cardiac valve replacements via catheter, eliminating the need for open-heart surgery.
Investors that may fit
Linear Capital
19 Robotics deals in the last 24 months · 2 at a nearby stage · 19 in 港澳台
Request intro →Shunwei Capital
16 Robotics deals in the last 24 months · 1 at a nearby stage · 16 in 港澳台
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.